Migration of mouse-induced pluripotent stem cells to glioma-conditioned medium is mediated by tumor-associated specific growth factors

Koizumi,Shinichiro; Gu,Chunyu; Amano,Shinji; Yamamoto,Seiji; Ihara,Hayato; Tokuyama,Tsutomu; Namba,Hiroki

doi:10.3892/ol.2011.234

Migration of mouse-induced pluripotent stem cells to glioma-conditioned medium is mediated by tumor-associated specific growth factors

Authors:
- Shinichiro Koizumi
- Chunyu Gu
- Shinji Amano
- Seiji Yamamoto
- Hayato Ihara
- Tsutomu Tokuyama
- Hiroki Namba
View Affiliations

Affiliations: Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan, Photon Medical Research Center, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan, Department of Psysiology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan
Published online on: January 14, 2011 https://doi.org/10.3892/ol.2011.234
Pages: 283-288

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neural and mesenchymal stem cells have extensive tropism for malignant glioma. The tumor tropism of induced pluripotent stem (iPS) cells was tested using the Matrigel invasion assay. Mouse iPS cells showed a significant tropism to the conditioned media prepared from six rodent and human glioma cell lines and this tropism to the glioma conditioned media was partially blocked by the neutralizing antibodies for four major tumor-associated growth factors [stem cell factor (SCF), platelet-derived growth factor BB (PDGF-BB), stromal-derived factor-1α (SDF-1α) and vascular endothelial growth factor (VEGF)], which are secreted from the malignant gliomas. The tropism of the iPS cells was enhanced by the growth factors in a concentration-dependent manner from 0.1 to 100 ng/ml. The receptors for those growth factors (c-Kit, ICAM-1, CXCR4 and VEGFR2), measured by reverse transcriptase-polymerase chain reaction, were highly up-regulated in the mouse iPS cells compared to the mouse fibroblasts. The results showed that the specific growth factors secreted from the gliomas strongly attracted the iPS cells. Therefore, gene therapies using iPS cells as vectors to deliver anti-tumor agents are novel strategies for the treatment of malignant gliomas that deeply infiltrate the brain.

View Figures

View References

1	Michotte A, Neyns B, Chaskis C, Sadones J and In’t Veld P: Neuropathological and molecular aspects of low-grade and high-grade gliomas. Acta Neurol Belg. 104:148–153. 2004.PubMed/NCBI
2	Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
3	Surawicz TS, Davis F, Freels S, Laws ER Jr and Menck HR: Brain tumor survival: results from the National Cancer Data Base. J Neurooncol. 40:151–160. 1998. View Article : Google Scholar : PubMed/NCBI
4	DeAngelis LM: Brain tumors. N Engl J Med. 344:114–123. 2001. View Article : Google Scholar
5	Nakamizo A, Marini F, Amano T, et al: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
6	Aboody KS, Brown A, Rainov NG, et al: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
7	Benedetti S, Pirola B, Pollo B, et al: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 6:447–450. 2000. View Article : Google Scholar : PubMed/NCBI
8	Ehtesham M, Kabos P, Gutierrez MA, et al: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 62:7170–7174. 2002.PubMed/NCBI
9	Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL and Yu JS: The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 62:5657–5663. 2002.PubMed/NCBI
10	Kim SK, Cargioli TG, Machluf M, et al: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res. 11:5965–5970. 2005. View Article : Google Scholar : PubMed/NCBI
11	Kim SK, Kim SU, Park IH, et al: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res. 12:5550–5556. 2006. View Article : Google Scholar
12	Lee DH, Ahn Y, Kim SU, et al: Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res. 15:4925–4934. 2009. View Article : Google Scholar : PubMed/NCBI
13	Sasportas LS, Kasmieh R, Wakimoto H, et al: Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA. 106:4822–4827. 2009. View Article : Google Scholar : PubMed/NCBI
14	Amano S, Li S, Gu C, et al: Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. Int J Oncol. 35:1265–1270. 2009.PubMed/NCBI
15	Li S, Gao Y, Tokuyama T, et al: Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett. 251:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
16	Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N and Namba H: Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology. 69:503–508. 2005. View Article : Google Scholar
17	Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N and Namba H: Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther. 12:600–607. 2005. View Article : Google Scholar : PubMed/NCBI
18	Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K and Sakiyama S: Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther. 9:5–11. 1998. View Article : Google Scholar : PubMed/NCBI
19	Schichor C, Birnbaum T, Etminan N, et al: Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol. 199:301–310. 2006. View Article : Google Scholar : PubMed/NCBI
20	Ehtesham M, Yuan X, Kabos P, et al: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia. 6:287–293. 2004. View Article : Google Scholar : PubMed/NCBI
21	Serfozo P, Schlarman MS, Pierret C, Maria BL and Kirk MD: Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines. Cancer Cell Int. 6:12006. View Article : Google Scholar : PubMed/NCBI
22	Hata N, Shinojima N, Gumin J, et al: Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery. 66:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
23	Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
24	Takahashi K, Okita K, Nakagawa M and Yamanaka S: Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2:3081–3089. 2007. View Article : Google Scholar : PubMed/NCBI
25	Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D and Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 53:4143–4147. 1993.PubMed/NCBI
26	Amabile G and Meissner A: Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 15:59–68. 2009. View Article : Google Scholar : PubMed/NCBI
27	Koch P, Kokaia Z, Lindvall O and Brustle O: Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol. 8:819–829. 2009. View Article : Google Scholar : PubMed/NCBI
28	Ronaghi M, Erceg S, Moreno-Manzano V and Stojkovic M: Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells. 28:93–99. 2010.PubMed/NCBI
29	Yu J and Thomson JA: Pluripotent stem cell lines. Genes Dev. 22:1987–1997. 2008. View Article : Google Scholar
30	Cheng P, Gao ZQ, Liu YH and Xue YX: Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neurosci Lett. 451:52–56. 2009. View Article : Google Scholar : PubMed/NCBI
31	Heese O, Disko A, Zirkel D, Westphal M and Lamszus K: Neural stem cell migration toward gliomas in vitro. Neuro Oncol. 7:476–484. 2005. View Article : Google Scholar : PubMed/NCBI
32	Brat DJ, Bellail AC and van Meir EG: The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
33	Mentlein R and Held-Feindt J: Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem. 83:747–753. 2002. View Article : Google Scholar : PubMed/NCBI
34	Teicher BA: Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 20:133–143. 2001. View Article : Google Scholar : PubMed/NCBI
35	Nagashima G, Suzuki R, Asai J and Fujimoto T: Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases. Clin Neurol Neurosurg. 104:125–131. 2002. View Article : Google Scholar
36	Dunn IF, Heese O and Black PM: Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol. 50:121–137. 2000. View Article : Google Scholar : PubMed/NCBI
37	Hamel W and Westphal M: Growth factors in gliomas revisited. Acta Neurochir. 142:113–138. 2000. View Article : Google Scholar : PubMed/NCBI
38	Das AV, James J, Zhao X, Rahnenfuhrer J and Ahmad I: Identification of c-Kit receptor as a regulator of adult neural stem cells in the mammalian eye: interactions with Notch signaling. Dev Biol. 273:87–105. 2004. View Article : Google Scholar : PubMed/NCBI
39	Tran PB, Ren D, Veldhouse TJ and Miller RJ: Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res. 76:20–34. 2004. View Article : Google Scholar : PubMed/NCBI
40	Baudino TA, McKay C, Pendeville-Samain H, et al: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16:2530–2543. 2002. View Article : Google Scholar : PubMed/NCBI
41	Miura K, Okada Y, Aoi T, et al: Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 27:743–745. 2009. View Article : Google Scholar : PubMed/NCBI